Scholarly Index
Toshitsugu Sugimoto
Ono Pharmaceutical (Japan); 18,244 total citations; 463 total publications; best world rank #109
Ono Pharmaceutical (Japan)
18,244Total citations
463Total publications
67H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Bone health and treatments | Lifetime | 134 | JP 6 | 99.23 |
| Bone Metabolism and Diseases | Lifetime | 109 | JP 9 | 99.12 |
| Bone and Joint Diseases | Lifetime | 120 | JP 3 | 98.90 |
| Bone health and osteoporosis research | Lifetime | 170 | JP 1 | 99.10 |
| Parathyroid Disorders and Treatments | Lifetime | 162 | JP 13 | 98.81 |
| Vitamin D Research Studies | Lifetime | 374 | JP 13 | 97.30 |
| Metabolism, Diabetes, and Cancer | Lifetime | 818 | JP 35 | 97.22 |
| TGF-β signaling in diseases | Lifetime | 232 | JP 21 | 96.40 |
| Growth Hormone and Insulin-like Growth Factors | Lifetime | 876 | JP 21 | 96.47 |
| Advanced Glycation End Products research | Lifetime | 438 | JP 64 | 94.82 |
| Hip and Femur Fractures | Lifetime | 955 | JP 12 | 95.44 |
| Alkaline Phosphatase Research Studies | Lifetime | 355 | JP 23 | 88.89 |
| Heterotopic Ossification and Related Conditions | Lifetime | 498 | JP 60 | 75.09 |